|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003385,
umls-concept:C0005682,
umls-concept:C0027740,
umls-concept:C0030797,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0289799,
umls-concept:C0441655,
umls-concept:C0529351,
umls-concept:C1280500,
umls-concept:C2917329
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-8-3
|
|
pubmed:abstractText |
Previous studies have revealed that intravesical and systemic administration of oxybutinin suppress pelvic afferent nerves. This study evaluates the efficacy of a selective M3 antimuscarinic, darifenacin, on bladder afferent activity.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0302-2838
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
European Association of Urology.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
842-7
|
|
pubmed:meshHeading |
pubmed-meshheading:17360104-Animals,
pubmed-meshheading:17360104-Benzofurans,
pubmed-meshheading:17360104-Female,
pubmed-meshheading:17360104-Injections, Intravenous,
pubmed-meshheading:17360104-Muscarinic Antagonists,
pubmed-meshheading:17360104-Neurons, Afferent,
pubmed-meshheading:17360104-Pelvis,
pubmed-meshheading:17360104-Pressure,
pubmed-meshheading:17360104-Pyrrolidines,
pubmed-meshheading:17360104-Rats,
pubmed-meshheading:17360104-Rats, Sprague-Dawley,
pubmed-meshheading:17360104-Receptor, Muscarinic M3,
pubmed-meshheading:17360104-Urinary Bladder,
pubmed-meshheading:17360104-Urodynamics
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve.
|
|
pubmed:affiliation |
Department of Urology, Faculty of Medicine, University Antwerp, Antwerp, Belgium.
|
|
pubmed:publicationType |
Journal Article
|
